Literature DB >> 14589724

Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests.

Martin L Rohling1, Paul Green, Lyle M Allen, Grant L Iverson.   

Abstract

This study examined the effect of depression on neurocognitive performance in patients who passed symptom validity testing. The Beck Depression Inventory (BDI) was used to assess depression in 420 patients with heterogeneous referral diagnoses (more than half of these cases were head injury or neurological disease). All patients had demonstrated satisfactory effort by passing two symptom validity tests. No differences were found on objective cognitive and psychomotor measures in groups sorted based on their self-reported depression. In contrast, on the self-report measures [i.e., Minnesota Multiphasic Personality Inventory-2 (MMPI-2), Symptom Checklist-90-Revised (SCL-90-R), and Memory Complaints Inventory (MCI)], differences were found indicating that patients with depression report more emotional, somatic, and cognitive problems. Contrary to expectation, these data suggest that depression has no impact on objective neurocognitive functioning.

Entities:  

Year:  2002        PMID: 14589724

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  14 in total

1.  [Negative response bias and the validity of personality profiles in neuropsychiatric assessment].

Authors:  T Merten; E Friedel; G Mehren; A Stevens
Journal:  Nervenarzt       Date:  2007-05       Impact factor: 1.214

2.  Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory.

Authors:  Shawn M McClintock; Munro Cullum; Mustafa M Husain; A John Rush; Rebecca G Knapp; Martina Mueller; Georgios Petrides; Shirlene Sampson; Charles H Kellner
Journal:  CNS Spectr       Date:  2010-05       Impact factor: 3.790

3.  Verbal learning and memory in older adults with minor and major depression.

Authors:  Raquelle I Mesholam-Gately; Anthony J Giuliano; Eric A Zillmer; Lamia P Barakat; Anand Kumar; Ruben C Gur; Lisa M McAndrew; Warren B Bilker; Virginia Elderkin-Thompson; Paul J Moberg
Journal:  Arch Clin Neuropsychol       Date:  2011-12-21       Impact factor: 2.813

4.  Is Poor Working Memory a Transdiagnostic Risk Factor for Psychopathology?

Authors:  Cynthia Huang-Pollock; Zvi Shapiro; Hilary Galloway-Long; Alex Weigard
Journal:  J Abnorm Child Psychol       Date:  2017-11

5.  Auditory memory decrements, without dissimulation, among patients with major depressive disorder.

Authors:  Ciaran M Considine; Sara L Weisenbach; Sara J Walker; E Michelle McFadden; Lindsay M Franti; Linas A Bieliauskas; Daniel F Maixner; Bruno Giordani; Stanley Berent; Scott A Langenecker
Journal:  Arch Clin Neuropsychol       Date:  2011-05-18       Impact factor: 2.813

6.  Identifying a cognitive impairment subgroup in adults with mood disorders.

Authors:  Grant L Iverson; Brian L Brooks; Scott A Langenecker; Allan H Young
Journal:  J Affect Disord       Date:  2011-03-25       Impact factor: 4.839

7.  [Neuropsychological assessment of suboptimal performance: the Word Memory Test].

Authors:  R Brockhaus; T Merten
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

8.  Differential Resting State Connectivity Patterns and Impaired Semantically Cued List Learning Test Performance in Early Course Remitted Major Depressive Disorder.

Authors:  Julia A Rao; Lisanne M Jenkins; Erica Hymen; Maia Feigon; Sara L Weisenbach; Jon-Kar Zubieta; Scott A Langenecker
Journal:  J Int Neuropsychol Soc       Date:  2016-02       Impact factor: 2.892

9.  "Feeling" hierarchy: the pathway from subjective social status to achievement.

Authors:  Mesmin Destin; Scott Richman; Fatima Varner; Jelani Mandara
Journal:  J Adolesc       Date:  2012-07-13

10.  Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Authors:  Ryan J Piers; Yulin Liu; Ting F A Ang; Qiushan Tao; Rhoda Au; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.